Sign Up
Stories
Adial Pharmaceuticals Boosts AD04 Development
Share
Adial Pharmaceuticals Raises Funds for A...
ADMA Biologics CFO Transition Announceme...
ADMA Biologics CFO Transition Revealed
ADOCIA Files 2023 Registration Document
Overview
API
Adial Pharmaceuticals exercises warrants generating $3.5 million to support AD04 drug activities for Alcohol Use Disorder. The funds will be used for general corporate needs, including regulatory and clinical support.
Ask a question
How might the exercise of warrants impact the development timeline of Adial Pharmaceuticals' AD04 drug?
In what ways could the success of AD04 impact the landscape of addiction treatment and related disorders?
What regulatory challenges might Adial Pharmaceuticals face in utilizing the raised funds for its clinical and regulatory activities?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage
finan
globe